Project Oncology®

192 Épisodes

1. Managing Myelofibrosis with a Patient-Centered Approach

   Publié: 17/04/2024
2. Exploring the Significant Presence of Anemia in Myelofibrosis

   Publié: 15/04/2024
3. Anemia and Myelofibrosis: Optimizing Diagnosis, Treatment, and Management Strategies

   Publié: 15/04/2024
4. Navigating Myelofibrosis Treatment Complexities to Optimize Care

   Publié: 09/04/2024
5. Maximizing B-Cell Lymphoma Outcomes with CAR T-Cell Therapy and Personalized Care

   Publié: 04/04/2024
6. B-Cell Lymphoma Care: Overcoming Challenges in the Second-Line Setting

   Publié: 04/04/2024
7. Managing B-Cell Lymphomas in the Second-Line Setting: The Role of CAR T-Cell Therapy

   Publié: 04/04/2024
8. Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights

   Publié: 13/03/2024
9. mCRPC Care: Reducing Progression Risk by Combining Enzalutamide and Talazoparib

   Publié: 20/02/2024
10. Prostate Cancer Research: Why Disparities Exist in Mortality and Trial Access

    Publié: 15/02/2024
11. Prostate Cancer Care: Improving Hormonal Therapy Sequencing Post-Treatment Intensification

    Publié: 09/02/2024
12. Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care

    Publié: 09/02/2024
13. The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey

    Publié: 29/01/2024
14. Emerging Strategies in Multi-Cancer Early Detection

    Publié: 29/01/2024
15. ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer

    Publié: 25/01/2024
16. Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU

    Publié: 25/01/2024
17. Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans

    Publié: 25/01/2024
18. Treating Patients with NSCLC: Decision-Making and Surgical Considerations

    Publié: 08/01/2024
19. NSCLC Care: Evaluating Durvalumab in the First-Line Setting

    Publié: 28/12/2023
20. How Do We Implement ANNEXXa-I Into Our Clinical Practice?

    Publié: 22/12/2023